835
Views
17
CrossRef citations to date
0
Altmetric
Review Articles

Biomedical nanomaterials: applications, toxicological concerns, and regulatory needs

ORCID Icon, & ORCID Icon
Pages 331-351 | Received 23 Aug 2020, Accepted 01 Dec 2020, Published online: 18 Dec 2020

References

  • Ahmed, K. B. R., A. M. Nagy, R. P. Brown, Q. Zhang, S. G. Malghan, and P. L. Goering. 2017. “Silver Nanoparticles: Significance of Physicochemical Properties and Assay Interference on the Interpretation of in Vitro Cytotoxicity Studies.” Toxicology in Vitro 38: 179–192. doi:10.1016/j.tiv.2016.10.012.
  • Alcaraz, J. P., G. Menassol, G. Penven, J. Thelu, S. EL Ichi, A. Zebda, P. Cinquin, and D. K. Martin,” 2020. “Challenges for the Implantation of Symbiotic Nanostructured Medical Devices.” Applied Sciences 10: 2923. doi:10.3390/app10082923.
  • Arias, L. S., J. P. Pessan, A. P. M. Vieira, T. M. T. DE Lima, A. C. B. Delbem, and D. R. Monteiro. 2018. “Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity.” Antibiotics 7 (2): 46. doi:10.3390/antibiotics7020046.
  • Azimzadeh, M., M. Rahaie, N. Nasirizadeh, K. Ashtari, and H. Naderi-Manesh. 2016. “An Electrochemical Nanobiosensor for Plasma miRNA-155, Based on Graphene Oxide and Gold Nanorod, for Early Detection of Breast Cancer.” Biosensors & Bioelectronics 77: 99–106. doi:10.1016/j.bios.2015.09.020.
  • Balasubramanian, K., and M. Burghard. 2006. “Biosensors Based on Carbon Nanotubes.” Analytical and Bioanalytical Chemistry 385 (3): 452–468. doi:10.1007/s00216-006-0314-8.
  • Barba, A., Y. Maazouz, A. Diez-Escudero, K. Rappe, M. Espanol, E. B. Montufar, C. Öhman-Mägi, et al. 2018. “Osteogenesis by Foamed and 3D-Printed Nanostructured Calcium Phosphate Scaffolds: Effect of Pore Architecture.” Acta Biomaterialia 79: 135–147. doi:10.1016/j.actbio.2018.09.003.
  • Beaudrie, C. E., M. Kandlikar, R. Gregory, G. Long, and T. Wilson. 2015. “Nanomaterial Risk Screening: A Structured Approach to Aid Decision Making under Uncertainty.” Environment Systems and Decisions 35 (1): 88–109. doi:10.1007/s10669-014-9529-y.
  • Boverhof, D. R., and R. M. David. 2010. “Nanomaterial Characterization: Considerations and Needs for Hazard Assessment and Safety Evaluation.” Analytical and Bioanalytical Chemistry 396 (3): 953–961. doi:10.1007/s00216-009-3103-3.
  • Brunner, T. J., P. Wick, P. Manser, P. Spohn, R. N. Grass, L. K. Limbach, A. Bruinink, and W. J. Stark. 2006. “In Vitro Cytotoxicity of Oxide Nanoparticles: Comparison to Asbestos, Silica, and the Effect of Particle Solubility.” Environmental Science & Technology 40 (14): 4374–4381. doi:10.1021/es052069i.
  • Buchholz, K. 2007. “Science–or Not? the Status and Dynamics of Biotechnology.” Biotechnology Journal 2 (9): 1154–1168. doi:10.1002/biot.200600222.
  • Buckley, A., J. Warren, A. Hodgson, T. Marczylo, K. Ignatyev, C. Guo, and R. Smith. 2017. “Slow Lung Clearance and Limited Translocation of Four Sizes of Inhaled Iridium Nanoparticles.” Particle and Fibre Toxicology 14 (1): 5. doi:10.1186/s12989-017-0185-5.
  • Burdușel, A. C., O. Gherasim, A. M. Grumezescu, L. Mogoantă, A. Ficai, and E. Andronescu. 2018. “Biomedical Applications of Silver Nanoparticles: An up-to-Date Overview.” Nanomaterials 8 (9): 681. doi:10.3390/nano8090681.
  • Caponetti, V., J. W. Trzcinski, A. Cantelli, R. Tavano, E. Papini, F. Mancin, and M. Montalti. 2019. “Self-Assembled Biocompatible Fluorescent Nanoparticles for Bioimaging.” Frontiers in Chemistry 7: 168. doi:10.3389/fchem.2019.00168.
  • Chen, F., Y. Zhu, J. Wu, P. Huang, and D. Cui. 2012. “Nanostructured Calcium Phosphates: Preparation and Their Application in Biomedicine.” Nano Biomedicine & Engineering 4: 9. doi:10.5101/nbe.v4i1.p41-49.
  • Cheng, C. C., J. J. Huang, A. A. Muhable, Z. S. Liao, S. Y. Huang, S. C. Lee, C. W. Chiu, and D. J. Lee. 2017a. “Supramolecular Fluorescent Nanoparticles Functionalized with Controllable Physical Properties and Temperature-Responsive Release Behavior.” Polymer Chemistry 8 (15): 2292–2298. doi:10.1039/C7PY00276A.
  • Cheng, C. C., Z. S. Liao, J. J. Huang, D. J. Lee, and J. K. Chen. 2017b. “Supramolecular Polymer Micelles as Universal Tools for Constructing High-Performance Fluorescent Nanoparticles.” Dyes and Pigments 137: 284–292. doi:10.1016/j.dyepig.2016.10.028.
  • Chhour, P., P. C. Naha, S. M. O’Neill, H. I. Litt, M. P. Reilly, V. A. Ferrari, and D. P. Cormode. 2016. “Labeling Monocytes with Gold Nanoparticles to Track Their Recruitment in Atherosclerosis with Computed Tomography.” Biomaterials 87: 93–103. doi:10.1016/j.biomaterials.2016.02.009.
  • Choi, H. S., Y. Ashitate, J. H. Lee, S. H. Kim, A. Matsui, N. Insin, M. G. Bawendi, M. Semmler-Behnke, J. V. Frangioni, and A. Tsuda. 2010. “Rapid Translocation of Nanoparticles from the Lung Airspaces to the Body.” Nature Biotechnology 28 (12): 1300–1303. doi:10.1038/nbt.1696.
  • Clark, R. A., K. Ghosh, and M. G. Tonnesen. 2007. “Tissue Engineering for Cutaneous Wounds.” The Journal of Investigative Dermatology 127 (5): 1018–1029. doi:10.1038/sj.jid.5700715.
  • Cochis, A., B. Azzimonti, C. Della Valle, E. DE Giglio, N. Bloise, L. Visai, S. Cometa, L. Rimondini, and R. Chiesa. 2016. “The Effect of Silver or Gallium Doped Titanium against the Multidrug Resistant Acinetobacter baumannii.” Biomaterials 80: 80–95. doi:10.1016/j.biomaterials.2015.11.042.
  • Cohen, J. M., G. M. Deloid, and P. Demokritou. 2015. “A Critical Review of in Vitro Dosimetry for Engineered Nanomaterials.” Nanomedicine (London, England) 10 (19): 3015–3032. doi:10.2217/nnm.15.129.
  • Commission, E. 2006. “Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Establishing a European Chemicals Agency, Amending Directive 1999/45/EC and Repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as Well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC.” Official Journal of the European Union 396: 1–849.
  • Delmaar, C. J., W. J. Peijnenburg, A. G. Oomen, J. Chen, W. H. DE Jong, A. J. Sips, Z. Wang, and M. V. Park. 2015. “A Practical Approach to Determine Dose Metrics for Nanomaterials.” Environmental Toxicology and Chemistry 34 (5): 1015–1022. doi:10.1002/etc.2878.
  • Deloid, G. M., J. M. Cohen, G. Pyrgiotakis, S. V. Pirela, A. Pal, J. Liu, J. Srebric, and P. Demokritou. 2015. “Advanced Computational Modeling for in Vitro Nanomaterial Dosimetry.” Particle and Fibre Toxicology 12: 32. doi:10.1186/s12989-015-0109-1.
  • Devaraj, N. K., E. J. Keliher, G. M. Thurber, M. Nahrendorf, and R. Weissleder. 2009. “18F Labeled Nanoparticles for in Vivo PET-CT Imaging.” Bioconjugate Chemistry 20 (2): 397–401. doi:10.1021/bc8004649.
  • DI Bucchianico, S., M. R. Fabbrizi, S. K. Misra, E. Valsami-Jones, D. Berhanu, P. Reip, E. Bergamaschi, and L. Migliore. 2013. “Multiple Cytotoxic and Genotoxic Effects Induced in Vitro by Differently Shaped Copper Oxide Nanomaterials.” Mutagenesis 28 (3): 287–299. doi:10.1093/mutage/get014.
  • Doak, S., B. Manshian, G. Jenkins, and N. Singh. 2012. “In Vitro Genotoxicity Testing Strategy for Nanomaterials and the Adaptation of Current OECD Guidelines.” Mutation Research/Genetic Toxicology and Environmental Mutagenesis 745 (1–2): 104–111. doi:10.1016/j.mrgentox.2011.09.013.
  • Dobrovolskaia, M. A., D. R. Germolec, and J. L. Weaver. 2009. “Evaluation of Nanoparticle Immunotoxicity.” Nature Nanotechnology 4 (7): 411–414. doi:10.1038/nnano.2009.175.
  • Docter, D., S. Strieth, D. Westmeier, O. Hayden, M. Gao, S. K. Knauer, and R. H. Stauber. 2015. “No King Without a Crown-impact of the Nanomaterial-protein Corona on Nanobiomedicine.” Nanomedicine (London, England) 10 (3): 503–519. doi:10.2217/nnm.14.184.
  • Dolez, P. I. 2015. “Nanomaterials Definitions, Classifications, and Applications.” Nanoengineering. Amsterdam, Netherlands: Elsevier.
  • Donaldson, K., and C. A. Poland. 2013. “Nanotoxicity: Challenging the Myth of Nano-Specific Toxicity.” Current Opinion in Biotechnology 24 (4): 724–734. doi:10.1016/j.copbio.2013.05.003.
  • Duvall, M., and A. Wyatt. 2011. Regulation of Nanotechnology and Nanomaterials at EPA and around the World: Recent Developments and Context. Washington, DC: Beveridge & Diamond, PC.
  • ECHA 2020. Nanomaterials [Online]. Accessed 18 March 2020. https://echa.europa.eu/regulations/nanomaterials
  • EL Badawy, A. M., R. G. Silva, B. Morris, K. G. Scheckel, M. T. Suidan, and T. M. Tolaymat. 2011. “Surface Charge-Dependent Toxicity of Silver Nanoparticles.” Environmental Science & Technology 45 (1): 283–287. doi:10.1021/es1034188.
  • Elahi, N., M. Kamali, and M. H. Baghersad. 2018. “Recent Biomedical Applications of Gold Nanoparticles: A Review.” Talanta 184: 537–556. doi:10.1016/j.talanta.2018.02.088.
  • Fahey, M., and P. A. Indelicato. 1994. “Bone Tunnel Enlargement after Anterior Cruciate Ligament Replacement.” The American Journal of Sports Medicine 22 (3): 410–414. doi:10.1177/036354659402200318.
  • Falkner, R., and N. Jaspers. 2012. “Regulating Nanotechnologies: Risk, Uncertainty and the Global Governance Gap.” Global Environmental Politics 12 (1): 30–55. doi:10.1162/GLEP_a_00096.
  • Fan, Z., L. Sun, Y. Huang, Y. Wang, and M. Zhang. 2016. “Bioinspired Fluorescent Dipeptide Nanoparticles for Targeted Cancer Cell Imaging and Real-Time Monitoring of Drug Release.” Nature Nanotechnology 11 (4): 388–394. doi:10.1038/nnano.2015.312.
  • Farrera, C., and B. Fadeel. 2015. “It Takes Two to Tango: Understanding the Interactions between Engineered Nanomaterials and the Immune System.” European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V 95 (Pt A): 3–12. doi:10.1016/j.ejpb.2015.03.007.
  • Fathi-Achachelouei, M., H. Knopf-Marques, D. E. Riberio, C. E. Silva, J. G. D. Barthès, E. Bat, A. Tezcaner, and N. E. Vrana. 2019. “Use of Nanoparticles in Tissue Engineering and Regenerative Medicine.” Frontiers in Bioengineering and Biotechnology 7: 113. doi:10.3389/fbioe.2019.00113.
  • Fleischer, S., and T. Dvir. 2013. “Tissue Engineering on the Nanoscale: Lessons from the Heart.” Current Opinion in Biotechnology 24 (4): 664–671. doi:10.1016/j.copbio.2012.10.016.
  • Furxhi, I., F. Murphy, M. Mullins, A. Arvanitis, and C. A. Poland. 2020. “Nanotoxicology Data for in Silico Tools: A Literature Review.” Nanotoxicology 14 (5): 612–626. doi:10.1080/17435390.2020.1729439.
  • Gajewicz, A., and T. Puzyn. 2019. Computational Nanotoxicology: Challenges and Perspectives. Boca Raton, FL: CRC Press.
  • Gao, X., Y. Cui, R. M. Levenson, L. W. Chung, and S. Nie. 2004. “In Vivo Cancer Targeting and Imaging with Semiconductor Quantum Dots.” Nature Biotechnology 22 (8): 969–976. doi:10.1038/nbt994.
  • Gao, A., R. Hang, X. Huang, L. Zhao, X. Zhang, L. Wang, B. Tang, S. Ma, and P. K. Chu. 2014. “The Effects of Titania Nanotubes with Embedded Silver Oxide Nanoparticles on Bacteria and Osteoblasts.” Biomaterials 35 (13): 4223–4235. doi:10.1016/j.biomaterials.2014.01.058.
  • Gao, X., and G. V. Lowry. 2018. “Progress towards Standardized and Validated Characterizations for Measuring Physicochemical Properties of Manufactured Nanomaterials Relevant to Nano Health and Safety Risks.” NanoImpact 9: 14–30. doi:10.1016/j.impact.2017.09.002.
  • Gebel, T., H. Foth, G. Damm, A. Freyberger, P. J. Kramer, W. Lilienblum, C. Röhl, et al. 2014. “Manufactured Nanomaterials: Categorization and Approaches to Hazard Assessment.” Archives of Toxicology 88 (12): 2191–2211. doi:10.1007/s00204-014-1383-7.
  • Geys, J., B. Nemery, and P. H. Hoet. 2010. “Assay Conditions Can Influence the Outcome of Cytotoxicity Tests of Nanomaterials: Better Assay Characterization is Needed to Compare Studies.” Toxicology in Vitro: An International Journal Published in Association with BIBRA 24 (2): 620–629. doi:10.1016/j.tiv.2009.10.007.
  • Glaus, C., R. Rossin, M. J. Welch, and G. Bao. 2010. “In Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent.” Bioconjugate Chemistry 21 (4): 715–722. doi:10.1021/bc900511j.
  • Gliga, A. R., S. Skoglund, I. O. Wallinder, B. Fadeel, and H. L. Karlsson. 2014. “Size-Dependent Cytotoxicity of Silver Nanoparticles in Human Lung Cells: The Role of Cellular Uptake, Agglomeration and Ag Release.” Particle and Fibre Toxicology 11: 11. doi:10.1186/1743-8977-11-11.
  • Godwin, H., C. Nameth, D. Avery, L. L. Bergeson, D. Bernard, E. Beryt, W. Boyes, S. Brown, A. J. Clippinger, and Y. Cohen. 2015. Nanomaterial Categorization for Assessing Risk Potential to Facilitate Regulatory Decision-Making. Washington, DC: ACS Publications.
  • Gonzalez, L., B. Sanderson, and M. Kirsch-Volders. 2011. “Adaptations of the in Vitro MN Assay for the Genotoxicity Assessment of Nanomaterials.” Mutagenesis 26 (1): 185–191. doi:10.1093/mutage/geq088.
  • Grand View Research I 2017. Nanomedicine Market Analysis by Products, Application, Nanomolecule & Segment Forecasts [Online]. Accessed 18 March 2020. https://www.grandviewresearch.com/industry-analysis/nanomedicine-market
  • Greish, K., G. Thiagarajan, H. Herd, R. Price, H. Bauer, D. Hubbard, A. Burckle, et al. 2012. “Size and Surface Charge Significantly Influence the Toxicity of Silica and Dendritic nanoparticles.” Nanotoxicology 6 (7): 713–723. doi:10.3109/17435390.2011.604442.
  • Guadagnini, R., B. Halamoda Kenzaoui, L. Walker, G. Pojana, Z. Magdolenova, D. Bilanicova, M. Saunders, et al. 2015. “Toxicity Screenings of Nanomaterials: Challenges Due to Interference with Assay Processes and Components of Classic in Vitro Tests.” Nanotoxicology 9 (1): 13–24. doi:10.3109/17435390.2013.829590.
  • Gunasekaran, T., T. Nigusse, and M. D. Dhanaraju. 2011. “Silver Nanoparticles as Real Topical Bullets for Wound Healing.” The Journal of the American College of Clinical Wound Specialists 3 (4): 82–96. doi:10.1016/j.jcws.2012.05.001.
  • Han, X. J., K. Xu, O. Taratula, and K. Farsad. 2019. “Applications of Nanoparticles in Biomedical Imaging.” Nanoscale 11 (3): 799–819. doi:10.1039/c8nr07769j.
  • Hansen, S. F., E. S. Michelson, A. Kamper, P. Borling, F. Stuer-Lauridsen, and A. Baun. 2008. “Categorization Framework to Aid Exposure Assessment of Nanomaterials in Consumer Products.” Ecotoxicology 17 (5): 438–447. doi:10.1007/s10646-008-0210-4.
  • Hasan, A., M. Morshed, A. Memic, S. Hassan, T. J. Webster, and H. E. S. Marei. 2018. “Nanoparticles in Tissue Engineering: Applications, Challenges and Prospects.” International Journal of Nanomedicine 13: 5637–5655. doi:10.2147/IJN.S153758.
  • Haute, D. V., and J. M. Berlin. 2017. “Challenges in Realizing Selectivity for Nanoparticle Biodistribution and Clearance: Lessons from Gold Nanoparticles.” Therapeutic Delivery 8 (9): 763–774. doi:10.4155/tde-2017-0057.
  • He, C., Y. Hu, L. Yin, C. Tang, and C. Yin. 2010. “Effects of Particle Size and Surface Charge on Cellular Uptake and Biodistribution of Polymeric Nanoparticles.” Biomaterials 31 (13): 3657–3666. doi:10.1016/j.biomaterials.2010.01.065.
  • Heidmann, I., and J. Milde. 2013. “Communication about Scientific Uncertainty: How Scientists and Science Journalists Deal with Uncertainties in Nanoparticle Research.” Environmental Sciences Europe 25 (1): 25. doi:10.1186/2190-4715-25-25.
  • Hofferber, E. M., J. A. Stapleton, and N. M. Iverson. 2020. “Single Walled Carbon Nanotubes as Optical Sensors for Biological Applications.” Journal of the Electrochemical Society 167 (3): 037530. doi:10.1149/1945-7111/ab64bf.
  • Holmes, B., X. Fang, A. Zarate, M. Keidar, and L. G. Zhang. 2016. “Enhanced Human Bone Marrow Mesenchymal Stem Cell Chondrogenic Differentiation in Electrospun Constructs with Carbon Nanomaterials.” Carbon 97: 1–13. doi:10.1016/j.carbon.2014.12.035.
  • Hoshino, A., K. Fujioka, T. Oku, M. Suga, Y. F. Sasaki, T. Ohta, M. Yasuhara, K. Suzuki, and K. Yamamoto. 2004. “Physicochemical Properties and Cellular Toxicity of Nanocrystal Quantum Dots Depend on Their Surface Modification.” Nano Letters 4 (11): 2163–2169. doi:10.1021/nl048715d.
  • Hu, X., S. Cook, P. Wang, and H. M. Hwang. 2009. “In Vitro Evaluation of Cytotoxicity of Engineered Metal Oxide Nanoparticles.” Science of the Total Environment 407 (8): 3070–3072. doi:10.1016/j.scitotenv.2009.01.033.
  • Hynes, R. O. 2009. “The Extracellular Matrix: Not Just Pretty Fibrils.” Science 326 (5957): 1216–1219. doi:10.1126/science.1176009.
  • Kar, S., S. Ghosh, and J. Leszczynskia. 2019. Computational Methods of Interspecies Nanotoxicity Extrapolation: A Step toward the Future. Computational Nanotoxicology. Singapore: Jenny Stanford Publishing.
  • Keshavarz, M., K. Moloudi, R. Paydar, Z. Abed, J. Beik, H. Ghaznavi, and A. Shakeri-Zadeh. 2018. “Alginate Hydrogel co-Loaded with Cisplatin and Gold Nanoparticles for Computed Tomography Image-Guided Chemotherapy.” Journal of Biomaterials Applications 33 (2): 161–169. doi:10.1177/0885328218782355.
  • Khezerlou, A., M. Alizadeh-Sani, M. Azizi-Lalabadi, and A. Ehsani. 2018. “Nanoparticles and Their Antimicrobial Properties against Pathogens Including Bacteria, Fungi, Parasites and Viruses.” Microbial Pathogenesis 123: 505–526. doi:10.1016/j.micpath.2018.08.008.
  • Kim, D., S. Park, J. H. Lee, Y. Y. Jeong, and S. Jon. 2007. “Antibiofouling Polymer-Coated Gold Nanoparticles as a Contrast Agent for in Vivo X-Ray Computed Tomography Imaging.” Journal of the American Chemical Society 129 (24): 7661–7665. doi:10.1021/ja071471p.
  • Kim, B. Y., J. T. Rutka, and W. C. Chan. 2010. “Nanomedicine.” The New England Journal of Medicine 363 (25): 2434–2443. doi:10.1056/NEJMra0912273.
  • Kodali, V., and B. D. Thrall. 2015. “Oxidative Stress and Nanomaterial-Cellular Interactions.” Studies on Experimental Toxicology and Pharmacology. Berlin, Germany: Springer.
  • Krug, H. F. 2014. “Nanosafety Research-are We On the Right Track.” Angewandte Chemie 53 (46): 12304–12319. doi:10.1002/anie.201403367.
  • Krug, H. F. 2018. “The Uncertainty with Nanosafety: Validity and Reliability of Published Data.” Colloids and Surfaces B Biointerfaces 172: 113–117. doi:10.1016/j.colsurfb.2018.08.036.
  • Kuehl, R., P. S. Brunetto, A.-K. Woischnig, M. Varisco, Z. Rajacic, J. Vosbeck, L. Terracciano, K. M. Fromm, and N. Khanna. 2016. “Preventing Implant-Associated Infections by Silver Coating.” Antimicrobial Agents and Chemotherapy 60 (4): 2467–2475. doi:10.1128/AAC.02934-15.
  • Kuempel, E. D., C. L. Geraci, and P. A. Schulte. 2012. “Risk Assessment and Risk Management of Nanomaterials in the Workplace: Translating Research to Practice.” The Annals of Occupational Hygiene 56 (5): 491–505. doi:10.1093/annhyg/mes040.
  • Lafleur, L., and P. Yager. 2013. “Medical Biosensors.” Biomaterials Science. Amsterdam, Netherlands: Elsevier.
  • Lehman, S. E., A. S. Morris, P. S. Mueller, A. K. Salem, V. H. Grassian, and S. C. Larsen. 2016. “Silica Nanoparticle-Generated ROS as a Predictor of Cellular Toxicity: Mechanistic Insights and Safety by Design.” Environmental Science Nano 3: 56–66. doi:10.1039/C5EN00179J.
  • Lin, W., X. Zhang, L. Qian, N. Yao, Y. Pan, and L. Zhang. 2017. “Doxorubicin-Loaded Unimolecular Micelle-Stabilized Gold Nanoparticles as a Theranostic Nanoplatform for Tumor-Targeted Chemotherapy and Computed Tomography Imaging.” Biomacromolecules 18 (12): 3869–3880. doi:10.1021/acs.biomac.7b00810.
  • Linkov, I., and F. K. Satterstrom. 2008. “Nanomaterial Risk Assessment and Risk Management.” Real-Time and Deliberative Decision Making. Berlin, Germany: Springer.
  • Lison, D., G. Vietti, and S. Van De Brule 2014. “Paracelsus in Nanotoxicology.” Particle and Fibre Toxicology 11: 35. doi:10.1186/s12989-014-0035-7.
  • Liu, G., J. Wang, J. Kim, M. R. Jan, and G. E. Collins. 2004. “Electrochemical Coding for Multiplexed Immunoassays of proteins.” Analytical Chemistry 76 (23): 7126–7130. doi:10.1021/ac049107l.
  • Loiseau, A., V. Asila, G. Boitel-Aullen, M. Lam, M. Salmain, and S. Boujday. 2019. “Silver-Based Plasmonic Nanoparticles for and Their Use in Biosensing.” Biosensors 9 (2): 78. doi:10.3390/bios9020078.
  • Maiti, D., X. M. Tong, X. Z. Mou, and K. Yang. 2019. “Carbon-Based Nanomaterials for Biomedical Applications: A Recent Study.” Frontiers in Pharmacology 9: 1401. doi:10.3389/fphar.2018.01401.
  • Makvandi, P., C. Y. Wang, E. N. Zare, A. Borzacchiello, L. N. Niu, and F. R. Tay. 2020. “Metal-Based Nanomaterials in Biomedical Applications: Antimicrobial Activity and Cytotoxicity Aspects.” Advanced Functional Materials 30 (22): 1910021. doi:10.1002/adfm.201910021.
  • Manke, A., L. Wang, and Y. Rojanasakul. 2013. “Mechanisms of Nanoparticle-Induced Oxidative Stress and Toxicity.” BioMed Research International 2013: 1–15. 2013. doi:10.1155/2013/942916.
  • Manuele, F. A. 2005. “Risk Assessment & Hierarchies of Control.” Professional Safety 50: 33–39.
  • Markstedt, K., A. Mantas, I. Tournier, H. Martínez Ávila, D. Hägg, and P. Gatenholm. 2015. “3D Bioprinting Human Chondrocytes with Nanocellulose-Alginate Bioink for Cartilage Tissue Engineering Applications.” Biomacromolecules 16 (5): 1489–1496. doi:10.1021/acs.biomac.5b00188.
  • Maynard, A. D. 2014. “A Decade of Uncertainty.” Nature Nanotechnology 9 (3): 159–160. doi:10.1038/nnano.2014.43.
  • Mech, A., K. Rasmussen, P. Jantunen, L. Aicher, M. Alessandrelli, U. Bernauer, E. A. J. Bleeker, et al. 2019. “Insights into Possibilities for Grouping and Read-across for Nanomaterials in EU Chemicals Legislation.” Nanotoxicology 13 (1): 119–141. doi:10.1080/17435390.2018.1513092.
  • Mi, P., D. Kokuryo, H. Cabral, H. Wu, Y. Terada, T. Saga, I. Aoki, N. Nishiyama, and K. Kataoka. 2016. “A pH-Activatable Nanoparticle with Signal-Amplification Capabilities for Non-Invasive Imaging of Tumour Malignancy.” Nature Nanotechnology 11 (8): 724–730. doi:10.1038/nnano.2016.72.
  • Miernicki, M., T. Hofmann, I. Eisenberger, F. VON DER Kammer, and A. Praetorius. 2019. “Legal and Practical Challenges in Classifying Nanomaterials according to Regulatory Definitions.” Nature Nanotechnology 14 (3): 208–216. doi:10.1038/s41565-019-0396-z.
  • Mohammed, L., H. G. Gomaa, D. Ragab, and J. Zhu. 2017. “Magnetic Nanoparticles for Environmental and Biomedical Applications: A Review.” Particuology 30: 1–14. doi:10.1016/j.partic.2016.06.001.
  • Mohanty, S. P., and E. Kougianos. 2006. “Biosensors: A Tutorial Review.” IEEE Potentials 25 (2): 35–40. doi:10.1109/MP.2006.1649009.
  • Nakamura, Y., A. Mochida, P. L. Choyke, and H. Kobayashi. 2016. “Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?” Bioconjugate Chemistry 27 (10): 2225–2238. doi:10.1021/acs.bioconjchem.6b00437.
  • Napierska, D., L. C. Thomassen, V. Rabolli, D. Lison, L. Gonzalez, M. Kirsch-Volders, J. A. Martens, and P. H. Hoet. 2009. “Size-dependent Cytotoxicity of Monodisperse Silica Nanoparticles in Human Endothelial Cells.” Small 5 (7): 846–853. doi:10.1002/smll.200800461.
  • Niu, M., H. Zhong, H. Shao, D. Hong, T. Ma, Ke Xu, X. Chen, J. Han, and J. Sun. 2016. “Shape-Dependent Genotoxicity of Mesoporous Silica Nanoparticles and Cellular Mechanisms.” Journal of Nanoscience and Nanotechnology 16 (3): 2313–2318. doi:10.1166/jnn.2016.10928.
  • Oberdörster, G., E. Oberdörster, and J. Oberdörster. 2005. “Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles.” Environmental Health Perspectives 113 (7): 823–839. doi:10.1289/ehp.7339.
  • Oksel, C., C. Y. Ma, J. J. Liu, T. Wilkins, and X. Z. Wang. 2015. “(Q) SAR Modelling of Nanomaterial Toxicity: A Critical Review.” Particuology 21: 1–19. doi:10.1016/j.partic.2014.12.001.
  • Oksel, C., C. Ma, and X. Wang. 2015. “Current Situation on the Availability of Nanostructure-Biological Activity Data.” SAR and QSAR in Environmental Research 26 (2): 79–94. doi:10.1080/1062936X.2014.993702.
  • Oksel, C., V. Subramanian, E. M. A. Semenzin, C. Y. D. Hristozov, X. Z. Wang, N. Hunt, A. Costa, et al. 2016. “Evaluation of Existing Control Measures in Reducing Health and Safety Risks of Engineered Nanomaterials.” Environmental Science: Nano 3: 869–882. doi:10.1039/C6EN00122J.
  • O’Leary, D. E. 2008. “Gartner’s Hype Cycle and Information System Research Issues.” International Journal of Accounting Information Systems 9: 240–252. doi:10.1016/j.accinf.2008.09.001.
  • Ong, K. J., T. J. MacCormack, R. J. Clark, J. D. Ede, V. A. Ortega, L. C. Felix, M. K. M. Dang, et al. 2014. “Widespread Nanoparticle-Assay Interference: Implications for Nanotoxicity Testing.” PLoS One 9 (3): e90650. doi:10.1371/journal.pone.0090650.
  • Pan, Y., S. Neuss, A. Leifert, M. Fischler, F. Wen, U. Simon, G. Schmid, W. Brandau, and W. Jahnen-Dechent. 2007. “Size-dependent Cytotoxicity of Gold Nanoparticles.” Small 3 (11): 1941–1949. doi:10.1002/smll.200700378.
  • Paradise, J. 2019. “Regulating Nanomedicine at the Food and Drug Administration.” AMA Journal of Ethics 21 (4): E347–E355. doi:10.1001/amajethics.2019.347.
  • Park, W., H. Shin, B. Choi, W. K. Rhim, K. Na, and D. Keun Han. 2020. Advanced Hybrid Nanomaterials for Biomedical Applications.” Progress in Materials Science 114: 100686. doi:10.1016/j.pmatsci.2020.100686.
  • Park, I. K., C. P. Ng, J. Wang, B. Chu, C. Yuan, S. Zhang, and S. H. Pun. 2008. “Determination of Nanoparticle Vehicle Unpackaging by MR Imaging of a T(2) Magnetic Relaxation Switch.” Biomaterials 29 (6): 724–732. doi:10.1016/j.biomaterials.2007.10.018.
  • Park, H. G., and M. K. Yeo. 2016. “Nanomaterial Regulatory Policy for Human Health and Environment.” Molecular & Cellular Toxicology 12: 223–236. doi:10.1007/s13273-016-0027-9.
  • Pecher, J., J. Huber, M. Winterhalder, A. Zumbusch, and S. Mecking. 2010. “Tailor-Made Conjugated Polymer Nanoparticles for Multicolor and Multiphoton Cell Imaging.” Biomacromolecules 11 (10): 2776–2780. doi:10.1021/bm100854a.
  • Peng, C., L. Zheng, Q. Chen, M. Shen, R. Guo, H. Wang, X. Cao, G. Zhang, and X. Shi. 2012. “PEGylated Dendrimer-Entrapped Gold Nanoparticles for in Vivo Blood Pool and Tumor Imaging by Computed Tomography.” Biomaterials 33 (4): 1107–1119. doi:10.1016/j.biomaterials.2011.10.052.
  • Powers, K. W., M. Palazuelos, B. M. Moudgil, and S. M. Roberts. 2007. “Characterization of the Size, Shape, and State of Dispersion of Nanoparticles for Toxicological Studies.” Nanotoxicology 1 (1): 42–51. doi:10.1080/17435390701314902.
  • Qiao, Y., J. An, and L. Ma. 2013. “Single Cell Array Based Assay for in Vitro Genotoxicity Study of Nanomaterials.” Analytical Chemistry 85 (8): 4107–4112. doi:10.1021/ac400242w.
  • Qu, B., X. Chu, G. Shen, and R. Yu. 2008. “A Novel Electrochemical Immunosensor Based on Colabeled Silica Nanoparticles for Determination of Total Prostate Specific Antigen in Human Serum.” Talanta 76 (4): 785–790. doi:10.1016/j.talanta.2008.04.026.
  • Rahmer, J., A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert. 2013. “Nanoparticle Encapsulation in Red Blood Cells Enables Blood-Pool Magnetic Particle Imaging Hours after Injection.” Physics in Medicine and Biology 58 (12): 3965–3977. doi:10.1088/0031-9155/58/12/3965.
  • Rasmussen, K., M. González, P. Kearns, J. R. Sintes, F. Rossi, and P. Sayre. 2016. “Review of Achievements of the OECD Working Party on Manufactured Nanomaterials’ Testing and Assessment Programme. From Exploratory Testing to Test Guidelines.” Regulatory Toxicology and Pharmacology 74: 147–160. doi:10.1016/j.yrtph.2015.11.004.
  • Rauscher, H., K. Rasmussen, and B. K. Sokull. 2017. “Regulatory Aspects of Nanomaterials in the EU.” Chemie Ingenieur Technik 89 (3): 224–231. doi:10.1002/cite.201600076.
  • Rauscher, H., G. Roebben, A. Mech, N. Gibson, V. Kestens, T. Linsinger, and J. R. Sintes. 2019. An Overview of Concepts and Terms Used in the European Commission’s Definition of Nanomaterial. EUR 29647 EN, European Commission, JRC, Ispra. doi:10.2760/459136.
  • Reach, E. 2018. “Commission Regulation (EU) 2018/1881 of 3 December 2018 Amending Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as Regards Annexes I, III, VI, VII, VIII, IX, X, XI, and XII. To Address Nanoforms of Substances.” Official Journal of the European Union 308: 1–20.
  • Resnik, D. B. 2019. “How Should Engineered Nanomaterials Be Regulated for Public and Environmental Health?” AMA Journal of Ethics 21: 363–369. doi:10.1001/amajethics.2019.363.
  • Riehemann, K., S. W. Schneider, T. A. Luger, B. Godin, M. Ferrari, and H. Fuchs. 2009. “Nanomedicine-challenge and Perspectives.” Angewandte Chemie 48 (5): 872–897. doi:10.1002/anie.200802585.
  • Robertson, D., and G. H. Williams. 2009. Clinical and Translational Science: Principles of Human Research. Cambridge, MA: Academic Press.
  • Robinson, R. L. M., I. Lynch, W. Peijnenburg, J. Rumble, F. Klaessig, C. Marquardt, H. Rauscher, T. Puzyn, R. Purian, and C. Åberg. 2016. “How Should the Completeness and Quality of Curated Nanomaterial Data Be Evaluated?” Nanoscale 8: 9919–9943. doi:10.1039/C5NR08944A.
  • Romero-Aburto, R., T. N. Narayanan, Y. Nagaoka, T. Hasumura, T. M. Mitcham, T. Fukuda, P. J. Cox, R. R. Bouchard, T. Maekawa, and D. S. Kumar. 2013. “Fluorinated Graphene Oxide; a New Multimodal Material for Biological Applications.” Advanced Materials 25: 5632–5637. doi:10.1002/adma201301804.
  • Roubert, F., M. G. Beuzelin-Ollivier, M. Hofmann-Amtenbrink, H. Hofmann, and A. Hool. 2016. “Nanostandardization” in Action: Implementing Standardization Processes in a Multidisciplinary Nanoparticle-Based Research and Development Project.” NanoEthics 10 (1): 41–62. doi:10.1007/s11569-015-0248-8.
  • Sampath, L., S. Kwon, M. A. Hall, R. E. Price, and E. M. Sevick-Muraca. 2010. “Detection of Cancer Metastases with a Dual-Labeled near-Infrared/Position Emission Tomography Imaging Agent.” Translational Oncology 3 (5): 307–217. doi:10.1593/tlo.10139.
  • Santos, L. M., D. Stanisic, U. J. Menezes, M. A. Mendonça, T. D. Barral, N. Seyffert, V. Azevedo, et al. 2019. “Biogenic Silver Nanoparticles as a Post-Surgical Treatment for Corynebacterium pseudotuberculosis Infection in Small Ruminants.” Frontiers in Microbiology 10: 824. doi:10.3389/fmicb.2019.00824.
  • Savolainen, K., H. Alenius, H. Norppa, L. Pylkkänen, T. Tuomi, and G. Kasper. 2010. “Risk Assessment of Engineered Nanomaterials and Nanotechnologies.” Toxicology 269 (2–3): 92–104. doi:10.1016/j.tox.2010.01.013.
  • Sayes, C. M., and D. B. Warheit. 2009. “Characterization of Nanomaterials for Toxicity Assessment.” Wiley Interdisciplinary Reviews – Nanomedicine and Nanobiotechnology 1 (6): 660–670. doi:10.1002/wnan.58.
  • Sireesha, M., V. Jagadeesh Babu, A. S. Kranthi Kiran, and S. Ramakrishna. 2018. “A Review on Carbon Nanotubes in Biosensor Devices and Their Applications in Medicine.” Nanocomposites 4 (2): 36–57. doi:10.1080/20550324.2018.1478765.
  • Smith, M. J., J. M. Brown, W. C. Zamboni, and N. J. Walker. 2014. “From Immunotoxicity to Nanotherapy: The Effects of Nanomaterials on the Immune System.” Toxicological Sciences: An Official Journal of the Society of Toxicology 138 (2): 249–255. doi:10.1093/toxsci/kfu005.
  • Tantra, R., C. Oksel, T. Puzyn, J. Wang, K. N. Robinson, X. Z. Wang, C. Y. Ma, and T. Wilkins. 2015. “Nano(Q)SAR: Challenges, Pitfalls and Perspectives.” Nanotoxicology 9 (5): 636–642. doi:10.3109/17435390.2014.952698.
  • Thakor, A. S., J. V. Jokerst, P. Ghanouni, J. L. Campbell, E. Mittra, and S. S. Gambhir. 2016. “Clinically Approved Nanoparticle Imaging Agents.” Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 57 (12): 1833–1837. doi:10.2967/jnumed.116.181362.
  • Tsoi, K. M., S. A. MacParland, X. Z. Ma, V. N. Spetzler, J. Echeverri, B. Ouyang, S. M. Fadel, et al. 2016. “Mechanism of Hard-Nanomaterial Clearance by the Liver.” Nature Materials 15 (11): 1212–1221. doi:10.1038/nmat4718.
  • Vassey, M. J., G. P. Figueredo, D. J. Scurr, A. S. Vasilevich, S. Vermeulen, A. Carlier, J. Luckett, et al. 2020. “Immune Modulation by Design: Using Topography to Control Human Monocyte Attachment and Macrophage Differentiation.” Advanced Science 7 (11): 1903392. doi:10.1002/advs.201903392.
  • Wagner, V., A. Dullaart, A. K. Bock, and A. Zweck. 2006. “The Emerging Nanomedicine Landscape.” Nature Biotechnology 24 (10): 1211–1217. doi:10.1038/nbt1006-1211.
  • Walkey, C. D., and W. C. Chan. 2012. “Understanding and Controlling the Interaction of Nanomaterials with Proteins in a Physiological Environment.” Chemical Society Reviews 41 (7): 2780–2799. doi:10.1039/C1CS15233E.
  • Wang, G., J. Zhang, A. H. Dewilde, A. K. Pal, D. Bello, J. M. Therrien, S. J. Braunhut, and K. A. Marx. 2012. “Understanding and Correcting for Carbon Nanotube Interferences with a Commercial LDH Cytotoxicity Assay.” Toxicology 299 (2–3): 99–111. doi:10.1016/j.tox.2012.05.012.
  • Warheit, D. B. 2008. “How Meaningful Are the Results of Nanotoxicity Studies in the Absence of Adequate Material Characterization?” Toxicological Sciences: An Official Journal of the Society of Toxicology 101 (2): 183–185. doi:10.1093/toxsci/kfm279.
  • Winkler, D. A. 2017. “Computational Modelling of Magnetic Nanoparticle Properties and in Vivo Responses.” Current Medicinal Chemistry 24 (5): 483–496. doi:10.2174/0929867323666161018141902.
  • Winkler, D. A. 2020. “Role of Artificial Intelligence and Machine Learning in Nanosafety.” Small 16 (36): e2001883. doi:10.1002/smll.202001883.
  • Winter, P. M., S. D. Caruthers, A. Kassner, T. D. Harris, L. K. Chinen, J. S. Allen, E. K. Lacy, H. Zhang, J. D. Robertson, and S. A. Wickline. 2003. “Molecular Imaging of Angiogenesis in Nascent Vx-2 Rabbit Tumors Using a Novel ανβ3-Targeted Nanoparticle and 1.5 Tesla Magnetic Resonance Imaging.” Cancer Research 63: 5838–5843.
  • Wongrakpanich, A., I. A. Mudunkotuwa, S. M. Geary, A. S. Morris, K. A. Mapuskar, D. R. Spitz, V. H. Grassian, and A. K. Salem. 2016. “Size-Dependent Cytotoxicity of Copper Oxide Nanoparticles in Lung Epithelial Cells.” Environmental Science Nano 3: 365–374. doi:10.1039/C5EN00271K.
  • Woźniak, A., A. Malankowska, G. Nowaczyk, B. F. Grześkowiak, K. Tuśnio, R. Słomski, A. Zaleska-Medynska, and S. Jurga. 2017. “Size and Shape-Dependent Cytotoxicity Profile of Gold Nanoparticles for Biomedical Applications.” Journal of Materials Science Materials in Medicine 28 (6): 92. doi:10.1007/s10856-017-5902-y.
  • Yan, L., F. Zhao, J. Wang, Y. Zhao. and Y. Zu. 2019. “A Safe‐by‐Design Strategy towards Safer Nanomaterials in Nanomedicines.” Advanced Materials 31: doi:1805391.10.1002/adma.20180539.
  • Yang, X., A. P. Gondikas, S. M. Marinakos, M. Auffan, J. Liu, H. Hsu-Kim, and J. N. Meyer. 2012. “Mechanism of Silver Nanoparticle Toxicity is Dependent on Dissolved Silver and Surface Coating in Caenorhabditis elegans.” Environmental Science & Technology 46 (2): 1119–1127. doi:10.1021/es202417t.
  • Yokel, R. A., and R. C. Macphail. 2011. “Engineered Nanomaterials: Exposures, Hazards, and Risk Prevention.” Journal of Occupational Medicine and Toxicology (London, England) 6: 7. doi:10.1186/1745-6673-6-7.
  • You, S., J. Li, W. Zhu, C. Yu, D. Mei, and S. Chen. 2018. “Nanoscale 3D Printing of Hydrogels for Cellular Tissue Engineering.” Journal of Materials Chemistry B 6 (15): 2187–2197. doi:10.1039/C8TB00301G.
  • Yu, Y., T. Yang, and T. Sun. 2020. “New Insights into the Synthesis, Toxicity and Applications of Gold Nanoparticles in CT Imaging and Treatment of Cancer.” Nanomedicine (London, England) 15 (11): 1127–1145. doi:10.2217/nnm-2019-0395.
  • Zhang, B., P. S. Lung, S. Zhao, Z. Chu, W. Chrzanowski, and Q. Li. 2017. “Shape Dependent Cytotoxicity of PLGA-PEG Nanoparticles on Human Cells.” Scientific Reports 7: 1–8. doi:10.1038/s41598-017-07588-9.
  • Zhang, Z., N. Mascheri, R. Dharmakumar, Z. Fan, T. Paunesku, G. Woloschak, and D. Li. 2009. “Superparamagnetic Iron Oxide Nanoparticle-Labeled Cells as an Effective Vehicle for Tracking the GFP Gene Marker Using Magnetic Resonance Imaging.” Cytotherapy 11 (1): 43–51. doi:10.1080/14653240802420243.
  • Zhang, X., X. Zhang, B. Yang, Y. Zhang, M. Liu, W. Liu, Y. Chen, and Y. Wei. 2014. “Fabrication of Water-Dispersible and Biocompatible Red Fluorescent Organic Nanoparticles via PEGylation of Aggregate Induced Emission Enhancement Dye and Their Cell Imaging Applications.” Colloids and Surfaces. B, Biointerfaces 113: 435–441. doi:10.1016/j.colsurfb.2013.09.031.
  • Zhao, Y., B. Pang, H. Luehmann, L. Detering, X. Yang, D. Sultan, S. Harpstrite, et al. 2016. “Gold Nanoparticles Doped with 199Au Atoms and Their Use for Targeted Cancer Imaging by SPECT.” Advanced Healthcare Materials 5 (8): 928–935. doi:10.1002/adhm.201500992.
  • Zhu, J. J., J. J. Li, and F. F. Cheng. 2013. “Quantum Dot-Fluorescence-Based Biosensing.” Quantum Dots for DNA Biosensing. Berlin, Germany: Springer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.